El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Miniatura

Fitxers

697988.pdf (105.94 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2017-10-01

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/172764

Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer disease in subjects with Down syndrome

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.3233/JAD-160827

Resum

Background: Alzheimer's disease (AD) is the main medical problem in older adults with Down syndrome (DS). Studies of cerebrospinal fluid (CSF) AD biomarkers are limited and the feasibility of lumbar puncture (LP) is controversial in this population. Objective: to analyze the frequency of complications after a LP in DS. Methods: we collected data from 80 adults with DS that underwent a LP within the Down Alzheimer Barcelona Neuroimaging Initiative. Demographics, cognitive status, headache history, and presence of complications after the LP were recorded in every subject. In 53 of them (active group), this information was collected following a semi-structured and validated protocol that actively looks for complications. Other variables related to the LP procedure were also recorded. A telephone interview to the caregiver was performed 5-7 days after the procedure to ask about complications. Data from 27 subjects (clinical practice group), from whom the presence of complications was obtained in a medical follow-up visit within the three months after the LP, were also included. Results: there were no adverse events in 90% of our participants. The most frequent complication was headache (6.25%); only one subject reported a typical post-lumbar puncture headache with moderate severity that required analgesic treatment. Dizziness (3.75%) and back pain (1.25%) were also reported. All the participants that reported complications belonged to the active group. Conclusion: LP can be safely performed to study CSF biomarkers in DS. The reported complications are qualitatively similar to the general population, but are less frequently reported, even when actively searched for.

Matèries

Líquid cefalorraquidi, Malaltia d'Alzheimer, Síndrome de Down, Punció lumbar

Matèries (anglès)

Cerebrospinal fluid, Alzheimer's disease, Down syndrome, Spinal puncture

Citació

Col·leccions

Articles publicats en revistes (Patologia i Terapèutica Experimental)

Citació

CARMONA-IRAGUI, Maria, SANTOS, Telma, VIDELA, Sebastià, FERNÁNDEZ, Susana, BENEJAM, Bessy, VIDELA, Laura, ALCOLEA, Daniel, BLENNOW, Kaj, BLESA GONZÁLEZ, Rafael, LLEO, Alberto, FORTEA ORMAECHEA, Juan. Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer disease in subjects with Down syndrome. _Journal of Alzheimer's Disease_. 2017. Vol. 55, núm. 4, pàgs. 1489-1496. [consulta: 6 de gener de 2026]. ISSN: 1387-2877. [Disponible a: https://hdl.handle.net/2445/172764]

Exportar metadades

JSON - METS

Compartir registre